Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

DNA blood test could lead to early cancer detection

12 June 2017

By Hannah Somers

Appeared in BioNews 904

A highly-sensitive DNA blood test could help detect cancer years before tumours are detected.

Researchers have developed a 'high-intensity' genomic sequencing test to identify the mutations present in the fragments of DNA released into the blood by cancer cells.

In contrast to previous tests which sequenced circulating tumour DNA (ctDNA) shed into the bloodstream by tumour cells, the new assay covers 508 genes -- 'almost ten times more of the genome than any other previously reported cell-free DNA assays at these sequencing depths,' said Dr Pedram Razavi, lead study author and medical oncologist at Memorial Sloan Kettering Cancer Center in the USA.

This enhanced coverage of the genome is important as even tumours of the same cancer type can carry mutations in different genes. 'The more of the genome that you cover, the higher the chances of finding mutations that come from the tumour,' Dr Razavi added.

Fragments of tumour DNA in the blood can be detected by a number of commercial tests to aid monitoring of cancer development in already-diagnosed patients. This study aimed to remove the need for biopsies from the tumours themselves, paving the way for earlier cancer detection.

The test used a high-intensity sequencing approach, covering almost two million bases of DNA. Each region of the genome was 'read' 60,000 times, creating a highly sensitive assay for a large portion of the genome.

The team collected blood from 124 patients diagnosed with metastatic breast, non-small cell lung, and prostate cancer. They isolated and sequenced ctDNA, along with DNA from the patient’s white blood cells. This control step allowed them to identify cancer-derived mutations in the ctDNA.

The group then compared these blood assay mutations with those identified in tumour tissue biopsies from the same patients. Of 864 mutations identified in tumour biopsies, 627 (73 percent) were found present in the bloodstream. In 89 percent of patients, at least one of the mutations identified in the tumour tissue was also found in the blood.

'The ability of this assay to detect ctDNA without prior knowledge of tumour sequencing results and with an unprecedented breadth of signals are both important findings that support the possible feasibility of applying this approach to detection of cancer at earlier stages,' said Dr Razavi.

'We continue to see promising reports about possible uses of circulating tumour DNA analysis. While this approach has a ways to go before it becomes a proven technology for early cancer detection, this research is an important step in that direction,' said Dr John Heymach, an expert at the American Society of Clinical Oncology (ASCO).

The results were presented at the 2017 ASCO annual meeting in Chicago last week.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

26 June 2017 - by Charlotte Spicer 
A new three-in-one blood test could progress personalised treatment for patients with prostate cancer...

02 May 2017 - by Dr Loredana Guglielmi 
Blood tests for tumour DNA could predict relapse of the most common type of lung cancer up to one year before clinical signs show up on patient's scans...
24 April 2017 - by Meghna Kataria 
A blood test could swiftly detect gene mutations found in lung cancer, allowing faster commencement of treatment...
13 March 2017 - by Dr Loredana Guglielmi 
Researchers have developed a new blood test that can not only detect cancer at an early stage, but can also indicate where the tumour is located in the body...
09 November 2015 - by Ayala Ochert 
Scientists say it may be possible to track the progress of cancer – and cancer treatment – in real time from fragments of tumour DNA that are shed into the bloodstream...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation